LINDEINDIA · Basic Materials · Specialty Chemicals
Composite scorecard: 43/100 — Quality 77 · Valuation 22 · Growth 14 · Momentum 48
| Share price | ₹6,996.50 |
| Market cap | ₹57,396 Cr |
| P/E ratio | 97.1 |
| P/B ratio | 14.4 |
| ROE | 15.1% |
| ROCE | 15.2% |
| Dividend yield | 0.07% |
| Book value | ₹468.56 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹2,531 Cr | ₹549 Cr | 36.0% |
| 2025 | ₹2,485 Cr | ₹455 Cr | 31.0% |
| 2024 | ₹2,769 Cr | ₹434 Cr | 25.0% |
| 2022 | ₹2,112 Cr | ₹507 Cr | 26.0% |
| 2021 | ₹1,471 Cr | ₹151 Cr | 25.0% |
Linde India Limited manufactures and sells industrial and medical gases in India. It operates through Gases, Related Products and Services; and Project Engineering Division segments. The Gases, Related Products and Services segment produces and sells oxygen, nitrogen, and argon gases. This segment engages in the provision of pipeline gas supply to steel, glass, and chemical industries; liquefied gases through cryogenic tankers to various industrial sectors; and compressed gas in cylinders to fabrication, manufacturing, and construction industries. It offers gases, such as medical oxygen, synth